The deal gives Kyowa access to a therapy for early-onset metachromatic leukodystrophy
News
SMC recommends Bayer’s cancer treatments for NHS Scotland use
Eligible patients in Scotland will now have access to Nubeqa and Stivarga
UKRI awards £41m to enhance UK research and innovation
The scheme will help ten projects establish research and innovation clusters
Study reveals diagnosis and treatment inequalities in NHS heart care
Researchers focused on four of the most common heart conditions in the UK
New University of Bristol study to aid strep A vaccine development
The study will offer new insights into the immune system’s response to iGAS
Elligo Health Research expands Study Marketplace with Syneos Health
The agreement builds on the companies’s existing partnership
UK launches its first national PET imaging platform for drug discovery
NPIP will transform medical research and provide better outcomes for patients
AstraZeneca reveals new research to improve drug discovery
The study used data from 50,000 people in the UK Biobank
Signant Health launches Signant Biotech for emerging biopharma organisations
The research approach will help small- to mid-sized organisations to advance their clinical studies
Evonetix installs first DNA synthesis development platform at ICL
It will be the company’s first platform to be installed in an external scientific setting
King Faisal Specialist and Research Centre achieves world-first fully robotic liver transplant
The approach reduces recovery times and lowers rates of complications
Kate Therapeutics and Capsida Biotherapeutics collaborate on gene therapies
The companies aim to bring gene therapies to patients sooner than traditional approaches
NIHR awards £97.5m to fund its new Research Support Service
NIHR awards £97.5m to fund its new Research Support Service
Vortex expands research at London Cancer Hub’s Innovation Gateway
The Cancer Hub aims to create a world-leading ecosystem for cancer research
Fewer MS patients are prescribed DMTs in UK compared to Europe
The study analysed and compared information from 65,000 MS patients
